A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

October 10, 2008

Single Dose of Diflucan Good for Thrush

A single 750 milligram dose of Diflucan (fluconazole) is as safe and effective as taking 150 mg of Diflucan once daily for 14 days in curing oral candidiasis, also known as thrush, according to a study in the October 7 issue of Clinical Infectious Diseases.

Oral candidiasis is a common infection in people living with HIV, particularly those with low CD4 counts. A single-dose therapy potentially increases convenience and lowers the cost of treatment. Several previous studies have found that a single dose of Diflucan at 150 mg was at least partially effective in curing oral candidiasis without relapse. These studies, however, were small and found higher relapse rates compared with standard 14-day dosing.

To determine the efficacy of higher dose Diflucan taken only once, Omar Hamza, MD, of the Muhimbili University of Health and Allied Sciences in Dar Es Salaam, Tanzania, and his colleagues enrolled 220 HIV-positive patients with oral candidiasis. Half received a single dose of 750 mg Diflucan and the other half received 150 mg Diflucan, taken once daily for 14 days.

The clinical cure rates of the two strategies, determined by the resolution of symptoms, were nearly identical at roughly 95 percent. Lab tests taken from scrapings of the tongue revealed that 84 percent of the single-dose treatment group had total clearance of the candida fungus, while 75 percent of the 14-day treatment group had clearance of the fungus. The rate of side effects, which typically involved mild stomach upset, was very low in both groups. The authors, therefore, conclude that single-dose 750 mg Diflucan treatment may be safely used in HIV-positive people diagnosed with oral candidiasis. These results do not, however, apply to vaginal candidiasis or candidiasis that is more widespread throughout the body.

Search: Diflucan, fluconazole, oral candidiasis, thrush, Omar Hamza, Muhimbili University


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    dlw8585
    Miami Gardens
    Florida


    sequoiamv
    San Jose
    California


    racine
    New York
    New York


    donnyp
    liberty
    Kentucky
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.